ArticleResults in chemistry2023
Convenient synthesis and in vitro activity of oxalyl bis(benzenesulfonylhydrazides) and related compounds.
Article in Results in chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Symmetrical oxalyl bis(benzenesulfonylhydrazides) [ObBSH] were conveniently prepared by reacting various sulfonyl hydrazides with oxalyl chloride in refluxing tetrahydrofuran (or toluene). The crude products were obtained practically as virtually pure compounds in high yields. While synthetic access to oxalyl bis(benzenesulfonylhydrazides) has been described in the literature, this report delineates a facile protocol for preparing such type of compounds under relatively mild conditions from inexpensive, commercially available, and chemically stable reagents. Non-symmetrical oxalyl ObBSH were also obtained via modified one-pot, two-step synthetic protocol. However, those products required purification due to contaminations arising from the concurrent formation of the symmetrical counterparts. These newly synthesized molecules were screened in an acetylcholinesterase in vitro enzymatic assay. Several compounds showed inhibitory potency in low micromolar range, which aligns with results reported previously for similar compounds. Overall, the synthetic protocols presented herein revisit the preparation of oxalyl bis(benzenesulfonylhydrazides), which have been previously characterized as blowing agents possessing potential for commercial applications and might be also further explored in search of bioactive properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.